Prospective Validation of a Points Score System Predicting 30-day Survival

Recruiting now

Conditions studied: Metastatic Cancer

In brief

This is a one-stage single-arm phase II clinical trial designed to prospectively test the survival prediction tool as developed by Lee et al on patients referred to radiation oncology for palliative treatments. Survival prediction score based on objective data including laboratory values, attendance to emergency room, and primary cancer origin will be assigned to each patient at time of enrollment.

Key facts

Study ID
NCT05100342
Run by
Indiana University
People needed
214
Starts
2022-09-12
Expected to finish
2027-12-01
Last updated by the study team
2026-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.